ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.865
+0.035 (1.91%)
Jun 1, 2026, 2:52 PM EDT - Market open
ProKidney Market Cap
ProKidney has a market cap or net worth of $563.34 million as of June 1, 2026. Its market cap has increased by 149.60% in one year.
Market Cap
563.34M
Enterprise Value
346.71M
1-Year Change
149.60%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $563.34M, an increase of 117.67%. That is a compound annual growth rate of 17.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 552.80M | -17.97% |
| Dec 31, 2025 | 673.90M | 36.72% |
| Dec 31, 2024 | 492.90M | 17.61% |
| Dec 29, 2023 | 419.10M | -73.75% |
| Dec 30, 2022 | 1.60B | 405.76% |
| Dec 31, 2021 | 315.70M | 21.99% |
| Jun 30, 2021 | 258.80M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arvinas | 579.40M |
| Valneva SE | 578.55M |
| Rigel Pharmaceuticals | 564.13M |
| First Tracks Biotherapeutics | 556.88M |
| AgomAb Therapeutics NV | 554.04M |
| Assembly Biosciences | 548.15M |
| MiMedx Group | 548.12M |
| Gyre Therapeutics | 540.01M |